Yet as clinical use grows, so does interest in how GLP1 medications affect skeletal health particularly their impact on bone density, remodeling, and fracture risk
Perceived influence from special interests is a problem, even if the interactions didnt alter the FDA or CDCs actions
further corroborated these outcomes with a systematic review of four prospective and ten retrospective real-world studies of oral semaglutide in patients with T2D [143]
Prior Authorization Requirements When Anthem does cover Wegovy or Zepbound, it typically requires prior authorization: Clinical Requirements BMI of 30 or higher, OR BMI of 27 or higher with at least one weight-related condition Documentation Requirements Medical records supporting the diagnosis Evidence of previous weight loss attempts Sometimes: trial of other weight loss medications first (step therapy) Initial approval period: Typically 6 to 12 months
At BHRC, a licensed physician reviews your case before any protocol is prescribed, interprets your follow-up labs, and is available for questions throughout your program
If you take insulin, a sulphonylurea, or a GLP-1 receptor agonist , increase your blood glucose self-monitoring and arrange a medication review before starting any supplement with potential glucose-lowering effects
